Novo Integrated Sciences, Inc. Accounts Receivable, Credit Loss Expense (Reversal)
Novo Integrated Sciences, Inc. reported Accounts Receivable, Credit Loss Expense (Reversal) of $237.41 thousand for the 12-month period ending 2014-12-31, per its 10-K filed 2016-03-25.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ProvisionForDoubtfulAccounts · last filed 2016-03-25
- Novo Integrated Sciences, Inc. accounts receivable, credit loss expense (reversal) for the quarter ending 2014-12-31 was $118.71K.
- Novo Integrated Sciences, Inc. accounts receivable, credit loss expense (reversal) for the quarter ending 2014-09-30 was $59.35K.
- Novo Integrated Sciences, Inc. accounts receivable, credit loss expense (reversal) for fiscal 2014 was $237.41K.
| Period end | Accounts Receivable, Credit Loss Expense (Reversal) 3 month | Accounts Receivable, Credit Loss Expense (Reversal) 6 month | Accounts Receivable, Credit Loss Expense (Reversal) 9 month | Accounts Receivable, Credit Loss Expense (Reversal) 12 month |
|---|---|---|---|---|
| 2014-12-31 | $118.71K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-25 | $178.06K derived: sum of 2 quarters · filed 2016-03-25 | $237.41K 10-K · filed 2016-03-25 | |
| 2014-09-30 | $59.35K 10-Q · filed 2015-10-30 | $118.71K 10-Q · filed 2015-10-30 |